Feasibility of a 8-week Telerehabilitation Program for Patients With Thoracic Neoplasia Receiving Chemotherapy (TELErp)
Feasibility of an Eight-week Telerehabilitation Program for Patients With Unresectable Thoracic Neoplasia Receiving Chemotherapy
Exercise-based rehabilitation improves physical function, fatigue and quality of life in patients with thoracic neoplasia. Consequently, the need for rehabilitation across the continuum of care in oncology is growing rapidly. However, the implementation of this type of intervention is limited because of many barriers such as patients' symptoms and poor accessibility to programs. In this context, healthcare systems should develop and implement new approaches to dispense these services. Consequently, telerehabilitation is a promising strategy to improve access and adherence to rehabilitation.
OBJECTIVES To investigate the feasibility, adherence and satisfaction of a home-based telerehabilitation program (TELERP) with real-time physiological parameters acquisition in patients with unresectable thoracic neoplasia receiving chemotherapy and to explore its effects on patients' functional capacity.
METHODS Five patients receiving chemotherapy followed an 8-week TELERP using real-time monitoring combined with interactive exercises. The TELERP included supervised (15) and unsupervised (9) strengthening and cardiovascular exercise sessions at a rate of 3 sessions/week. The feasibility of the TELERP, adverse outcomes, technical issues, program adherence and satisfaction were analysed. Prior to and after the program, a six-minute walking test (6MWT), a timed up and go (TUG) and a timed stair test (TST) were done to assess functional capacity
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Quebec, Canada
- CRIUCPQ
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Patients had to have an ECOG functional status of 0 (Asymptomatic) or 1 (Symptomatic but completely ambulatory);
- Have a sufficient understanding of verbal and written French instructions
- Live in a geographic region served by a high speed Internet connection.
Exclusion Criteria:
- oxygen pulsed saturation (SpO2) <80% during the cardiopulmonary exercise test
- contraindications to exercise testing according to the American Thoracic Society and American College of Chest Physicians Exercise Testing Guidelines
- cerebral or bone metastasis
- a history of significant cardiovascular disease, hypertension, diabetes or musculoskeletal concerns that might limit their ability to perform active exercises
- severe psychiatric illness compromising adherence to the rehabilitation training routine.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Telerehabilitation group
Patients with unresectable thoracic neoplasia receiving chemotherapy treatment
|
The intervention was an 8-week home-based telerehabilitation program (three sessions of about 75 minutes per week) using the eChez-Soi telerehabilitation platform. Through a unique software interface, the eChez-Soi allows for the following three technological aspects: 1- continuous data acquisition and recording from commercial biometric sensors; 2- continuous transmission of the collected data via the Internet to the clinician's computer, allowing the clinician to visualize the biomechanical and physiological parameters in real time; and 3- a challenging gaming environment with interactive exercises performed on musical rhythms. In total, 15 supervised sessions and 9 unsupervised sessions were planned for a total of 24 exercise sessions |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Number of adverse events during the 8-week telerehabilitation program
Lasso di tempo: Along the 8-week program
|
Along the 8-week program
|
|
|
Adherence of the participants to the 8-week telerehabilitation program.
Lasso di tempo: Along the 8-week program
|
Adherence was defined as the number of sessions done over the prescribed sessions (supervised and unsupervised) and as percentage of time spent within the target heart rate range (intensities) throughout the cardiovascular exercise sessions
|
Along the 8-week program
|
|
Participants satisfaction with the telerehabilitation platform with the Québec User Evaluation of Satisfaction with Assistive Technology questionnaire (QUEST 2.0)
Lasso di tempo: At the end of the 8-week telerehabilitation program
|
The satisfaction of the patients was evaluated using a questionnaire adapted from the Québec User Evaluation of Satisfaction with Assistive Technology questionnaire (QUEST 2.0) that calculates both satisfaction scores for technological aspects and services.
It consists of 12 items rated on a scale from 1 to 5 (1: not satisfied at all to 5: very satisfied).
|
At the end of the 8-week telerehabilitation program
|
|
User satisfaction with health services received with the French version of the Health Care Satisfaction Questionnaire
Lasso di tempo: At the end of the 8-week telerehabilitation program
|
To assess more specifically the user satisfaction with health services received, we used the French version of the Health Care Satisfaction Questionnaire.
This is a 26-item questionnaire answered on a four-point Likert scale, where ''1'' represents ''not at all satisfied'' and ''4'' represents ''highly satisfied".
The total score is calculated in percentage and can be computed as the mean overall satisfaction divided in three domains: i) relationship with the professional, ii) delivery of services and iii) organization of services.
Higher scores indicate a higher level of satisfaction.
|
At the end of the 8-week telerehabilitation program
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Cardiopulmonary maximal exercise test (CPET)
Lasso di tempo: At baseline and following the 8-week program
|
At baseline and following the 8-week program
|
|
|
Constant workrate cycle exercise test at 80% of the maximal capacity of the patient
Lasso di tempo: At baseline and following the 8-week program
|
At baseline and following the 8-week program
|
|
|
Isokinetic quadriceps muscle functions
Lasso di tempo: At baseline and following the 8-week program
|
Quadriceps muscle function (strength and endurance) was assessed during an isokinetic endurance test performed at a rate of 30 repetitions at 90°/sec of angular velocity (Biodex, system pro 4, Biodex Medical System, 20 Ramsay Road, Shirley, New York )
|
At baseline and following the 8-week program
|
|
Lean body mass
Lasso di tempo: At baseline and following the 8-week program
|
Lean body mass (in Kg) were measured by bioelectrical impedance analysis (TBF-300WA Tanita, Arlington Heights, IL, USA)
|
At baseline and following the 8-week program
|
|
Fat body mass
Lasso di tempo: At baseline and following the 8-week program
|
Fat body mass (in Kg) were measured by bioelectrical impedance analysis (TBF-300WA Tanita, Arlington Heights, IL, USA)
|
At baseline and following the 8-week program
|
|
Weight
Lasso di tempo: At baseline and following the 8-week program
|
Weight (in Kg) of the patient
|
At baseline and following the 8-week program
|
|
Height
Lasso di tempo: At baseline and following the 8-week program
|
Height (in meters) of the patient
|
At baseline and following the 8-week program
|
|
Timed up and go test
Lasso di tempo: At baseline and following the 8-week program
|
At baseline and following the 8-week program
|
|
|
Timed stairs test
Lasso di tempo: At baseline and following the 8-week program
|
At baseline and following the 8-week program
|
|
|
Distance achieved during the 6 minutes walking test
Lasso di tempo: At baseline and following the 8-week program
|
At baseline and following the 8-week program
|
|
|
Cancer specific quality of life with the self-reported European Organization for Research and Treatment of Cancer Quality of Life Questionnaire questionnaire
Lasso di tempo: At baseline and following the 8-week program
|
The cancer related quality of life was assessed using the self-reported European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-30) including the lung cancer specific questionnaire QLQ-LC13
|
At baseline and following the 8-week program
|
|
Anxiety and depression with the Hospital Anxiety and Depression Scale questionnaire
Lasso di tempo: At baseline and following the 8-week program
|
The French Canadian version of the Hospital Anxiety and Depression Scale (HADS) was used to identify patients suffering of anxiety disorders or depression
|
At baseline and following the 8-week program
|
|
Nutritional status with the mini-nutritional assessment
Lasso di tempo: At baseline and following the 8-week program
|
At baseline and following the 8-week program
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Anticipato)
Completamento dello studio (Anticipato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 20994
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .